Evidence map›Paper›PMID 34259560›Full record

ArticlemSphere2021

Seroprevalence of Flavivirus Neutralizing Antibodies in Thailand by High-Throughput Neutralization Assay: Endemic Circulation of Zika Virus before 2012.

Atsushi Yamanaka, Mami Matsuda, Tamaki Okabayashi, Pannamthip Pitaksajjakul, Pongrama Ramasoota, Kyoko Saito, Masayoshi Fukasawa, Kentaro Hanada, Tomokazu Matsuura, Masamichi Muramatsu and 2 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Atsushi Yamanaka *Mahidol-Osaka Center for Infectious Diseases, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Mami Matsuda *Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Tamaki OkabayashiCenter for Animal Disease Control, University of Miyazaki, Miyazaki, Japan.
Pannamthip PitaksajjakulDepartment of Social and Environmental Medicine, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Pongrama RamasootaDepartment of Social and Environmental Medicine, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Kyoko SaitoDepartment of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan.
Masayoshi FukasawaDepartment of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan.
Kentaro HanadaDepartment of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo, Japan.
Tomokazu MatsuuraDepartment of Laboratory Medicine, The Jikei University School of Medicine, Tokyo, Japan.
Masamichi MuramatsuDepartment of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Tatsuo ShiodaMahidol-Osaka Center for Infectious Diseases, Faculty of Tropical Medicine, Mahidol Universitygrid.10223.32, Bangkok, Thailand.
Ryosuke SuzukiDepartment of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Mahidol University · THNational Institute of Infectious Diseases · JPJikei University School of Medicine · JPTokyo University of Science · JPUniversity of Miyazaki · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thailand is a hyperendemic country for flavivirus infections in Southeast Asia. Although the reporting system for flavivirus surveillance in Thailand is well established, syndromic surveillance tends to underestimate the true epidemiological status of flaviviruses due to the majority of infections being asymptomatic. To accurately understand the prevalence of flaviviruses in endemic regions, we performed neutralization tests against multiple flaviviruses using 147 serum samples from healthy donors collected from four distinct regions in Thailand. Single-round infectious particles (SRIP) for six flaviviruses, dengue virus types 1 to 4 (DENV-1 to -4), Japanese encephalitis virus (JEV), and Zika virus (ZIKV), were used as antigens for developing a safe, high-throughput neutralization assay. Titers of neutralizing antibodies (NAbs) against the six flaviviruses revealed that DENV-1 and DENV-2, followed by ZIKV were the predominant circulating flaviviruses in a total of four regions, whereas the prevalence of NAbs against JEV varied among regions. Although the seroprevalence of ZIKV was low relative to that of DENV-1 and DENV-2, the findings strongly suggested that ZIKV has been circulating at a sustained level in Thailand since before 2012. These findings not only demonstrated the application of an SRIP-neutralization test in a serological study, but also elucidated the circulation and distribution trends of different flaviviruses in Thailand.

Indexed as

AdolescentAdultAntibodies, NeutralizingAntibodies, ViralChildCross ReactionsDengue VirusFemaleFlavivirusFlavivirus InfectionsHigh-Throughput Screening AssaysHumansMaleMiddle AgedNeutralization TestsSeroepidemiologic StudiesAntibodies, NeutralizingAntibodies, Viraldengue virusflavivirus seroprevalenceneutralizing antibodysingle-round infectious particlesZika virus

Identifiers

PMID34259560
PMCPMC8386448
OpenAlexW3179393958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.